CIK 0001620463
- Non-accelerated filer
- Smaller reporting company
LeonaBio, Inc.
Sign in to watch- Ticker
- LONA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 453368487
- Phone
- +1 425-620-8501
- Business address
- 18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
- Former names
- Athira Pharma, Inc., M3 Biotechnology, Inc.
- 4 Open-market sale Chief Financial Officer sold 2,614 shares at $2.69 ($7,032)
- 4 Open-market sale Chief Executive Officer sold 7,960 shares at $2.69 ($21,412)
- 4 Open-market sale Chief Operating Officer sold 4,193 shares at $2.69 ($11,279)
- 4 Open-market sale Executive VP, Research sold 2,614 shares at $2.69 ($7,032)
- 4 Exercise or conversion Executive VP, Research acquired 2,500 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Chief Financial Officer acquired 3,000 shares (option exercise)
- 4 Open-market buy Director bought 8,000 shares at $13.11 ($104,880)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3/A Insider 3/A
- 4 Exercise or conversion Executive VP, Research acquired 3,152 shares (option exercise)
- 4 Grant or award Chief Executive Officer acquired 885 shares (grant or award)
Page 8 of 11 · 211 filings